Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A gelatin based pH responsive composite hydrogel has been synthesised by grafting β-cyclodextrin (β-CD) to gelatin (Gel) and crosslinking with oxidised dextran (OX-Dex). This pH sensitive β-CD grafted Gel crosslinked with OX-Dex (β-CD-g-Gel/OX-Dex) or composite hydrogel (CHG) was used to investigate the colon delivery of 5-fluorouracil (5-FLU), an anti cancer drug. Fourier Transform Infrared Spectroscopy (FTIR) was used to confirm the grafting of β-CD, crosslinking and drug encapsulation. Powder X-ray diffraction (PXRD) reveals the amorphous character of CHG. Factors affecting the swelling were thoroughly studied. The grafting of β-CD enhanced the drug encapsulation capacity. Release data were fitted to empirical equations to understand the nature of the drug release profiles. The drug release profile followed the Higuchi model. Degradation and swelling of the hydrogel were found to contribute to the release of drug. Release profiles of 5-FLU were studied both at gastric pH (1.2) and at intestinal pH (7.4); the results showed that release is very low at pH 1.2 and high at pH 7.4. An in vitro cytotoxicity study was carried out on human colon cancer cells; the results showed that drug loaded β-CD-g-Gel/OX-Dex (CHG) showed enhanced cell inhibition compared to the drug alone. Results of the present investigation exemplify the potential of this novel pH switchable composite hydrogel for the controlled and targeted delivery of the anti cancer drug 5-FLU.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Hydrogels: From controlled release to pH-responsive drug delivery
Gupta, P., Vermani, K., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02255-9 · Cited by 1,825
Cited by
Rizwan, M., Yahya, R., Hassan, A., Yar, M., Azzahari, A., Selvanathan, V., Sonsudin, F., & Abouloula, C. (2017) · Polymers · doi:10.3390/polym9040137 · Cited by 844
pH-Responsive carriers for oral drug delivery: Challenges and opportunities of current platforms
Liu, L., Yao, W., Rao, Y., Lu, X., & Gao, J. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1279238 · Cited by 420
pH ‐responsive polymers for drug delivery: Trends and opportunities
Singh, J., & Nayak, P. (2023) · Journal of Polymer Science · doi:10.1002/pol.20230403 · Cited by 327
Ali, A., & Ahmed, S. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01052 · Cited by 304
Review of Stimuli-Responsive Polymers in Drug Delivery and Textile Application
CHATTERJEE, S., & Chi-leung HUI, P. (2019) · Molecules · doi:10.3390/molecules24142547 · Cited by 201
“The gelatin-based pH-responsive hydrogel was developed by grafting β-cyclodextrin to gelatin (Gel), which is followed by cross-linking with oxidized dextran and the hydrogel was used as a drug delivery system for anti-cancer drug 5-fluorouracil [94].”
Method
Metadata
- Authors
- Anirudhan, T. S., & Mohan, A. M.
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 4
- Issue
- 24
- Pages
- 12109
- ISSN
- 2046-2069 (ISSN-L)
- OpenAlex
- W2073848656
- Cited by
- 102
- References
- 2
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil. https://app.cochat.ai/papers/10.1039/c3ra47991a
- The paper
- Anirudhan, T. S., & Mohan, A. M. (2014). Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil. RSC Advances. https://doi.org/10.1039/c3ra47991a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.